Literature DB >> 3099601

Glucose metabolism during liver transplantation in dogs.

A M DeWolf, Y G Kang, S Todo, I Kam, A J Francavilla, L Polimeno, S Lynch, T E Starzl.   

Abstract

Arterial and hepatic venous blood levels of glucose were studied in 12 dogs during orthotopic liver transplantation performed under ketamine anesthesia without exogenous glucose administration. During the early part of surgery, arterial blood glucose levels were stable: 161 +/- 12 mg/dl (mean +/- SEM) after laparotomy and 183 +/- 16 mg/dl 5 min before the anhepatic stage. During the anhepatic stage, arterial blood glucose levels decreased progressively to 135 +/- 9 and 88 +/- 8 mg/dl, 5 min in the anhepatic stage and 5 min before reperfusion of the graft liver, respectively (P less than 0.05). Reperfusion of the graft liver resulted in an increase in arterial glucose levels to 206 +/- 17 and 240 +/- 24 mg/dl, 5 and 30 min after reperfusion, respectively (P less than 0.05). Hepatic venous blood glucose levels increased after reperfusion (405 +/- 37 and 346 +/- 41 mg/dl, 5 and 30 min after reperfusion, respectively) and were significantly higher than in arterial blood (P less than 0.05). Arterial plasma insulin, measured in five animals, did not change significantly during the procedure, whereas plasma glucagon levels, stable during the preanhepatic and anhepatic stages, increased steadily after reperfusion of the graft liver, from 66.1 +/- 14.2 to 108.4 +/- 38.1 pg/ml (P less than 0.05). This study shows that in dogs with ketamine anesthesia mild hypoglycemia occurs during the anhepatic stage of liver transplantation without exogenous glucose administration followed by hyperglycemia on reperfusion of the graft liver, possibly secondary to the release of glucose from the donor liver.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3099601      PMCID: PMC2955426     

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  9 in total

Review 1.  Receptors, antireceptor antibodies and mechanisms of insulin resistance.

Authors:  J S Flier; C R Kahn; J Roth
Journal:  N Engl J Med       Date:  1979-02-22       Impact factor: 91.245

2.  Biochemical aspects of experimental hepatic allotransplantation.

Authors:  J P Halliday; A G Sheil; W J Hensley; M J Bookallil; G P Wotherspoon
Journal:  Arch Surg       Date:  1974-01

3.  Elevated plasma glucagon levels in cirrhosis of the liver.

Authors:  J Marco; J Diego; M L Villanueva; M Diaz-Fierros; I Valverde; J M Segovia
Journal:  N Engl J Med       Date:  1973-11-22       Impact factor: 91.245

4.  Glucose intolerance and insulin resistance in patients with liver disease. II. A study of etiologic factors and evaluation of insulin actions.

Authors:  J R Collins; W W Lacy; J N Stiel; O B Crofford
Journal:  Arch Intern Med       Date:  1970-10

Review 5.  Animal research in liver transplantation with special reference to the dog.

Authors:  S Todo; I Kam; S Lynch; T E Starzl
Journal:  Semin Liver Dis       Date:  1985-11       Impact factor: 6.115

Review 6.  Evolution of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; D H Van Thiel; J C Gartner; B J Zitelli; J J Malatack; R R Schade; B W Shaw; T R Hakala; J T Rosenthal; K A Porter
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

7.  Anesthesia for hepatic transplantation: cardiovascular and metabolic alterations and their management.

Authors:  F J Carmichael; M J Lindop; J V Farman
Journal:  Anesth Analg       Date:  1985-02       Impact factor: 5.108

8.  Venous bypass in clinical liver transplantation.

Authors:  B W Shaw; D J Martin; J M Marquez; Y G Kang; A C Bugbee; S Iwatsuki; B P Griffith; R L Hardesty; H T Bahnson; T E Starzl
Journal:  Ann Surg       Date:  1984-10       Impact factor: 12.969

9.  Anesthesia for pediatric orthotopic liver transplantation.

Authors:  L M Borland; M Roule; D R Cook
Journal:  Anesth Analg       Date:  1985-02       Impact factor: 5.108

  9 in total
  1 in total

1.  Dextrose in the banked blood products does not seem to affect the blood glucose levels in patients undergoing liver transplantation.

Authors:  Kwok-Wai Cheng; Chao-Long Chen; Yu-Fan Cheng; Chia-Chih Tseng; Chih-Hsien Wang; Yaw-Sen Chen; Chih-Chi Wang; Tung-Liang Huang; Hock-Liew Eng; King-Wah Chiu; Shih-Hor Wang; Chih-Che Lin; Tsan-Shiun Lin; Yueh-Wei Liu; Bruno Jawan
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.